About That Finding…

Medical studies that show large effects often don't hold up under further scrutiny, a new paper published in the Journal of the American Medical Association says. Stanford University's John Ioannidis and his colleagues analyzed clinical trial data from the Cochrane Database of Systematic Reviews and found that "when additional evidence is obtained, most of the very large treatment effects become much smaller and many lose their nominal significance," the authors write.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.